The iPLA2γ is identified as the membrane potential sensitive phospholipase in liver mitochondria  by Rauckhorst, Adam J. et al.
FEBS Letters 589 (2015) 2367–2371journal homepage: www.FEBSLetters .orgThe iPLA2c is identiﬁed as the membrane potential sensitive
phospholipase in liver mitochondriahttp://dx.doi.org/10.1016/j.febslet.2015.07.016
0014-5793/ 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
Author contributions: A.J.R., D.R.P., and K.M.B. contributed to preparing this
manuscript. A.J.R., D.R.P., and K.M.B. contributed to revisions of this manuscript.
A.J.R., D.R.P., and K.M.B. contributed to discussions regarding the design of the
experiments conducted. A.J.R. and K.M.B. conducted the experiments.
⇑ Corresponding author at: 525 S. Main Street, Meyer 270, Ada, OH 45810, United
States. Fax: +1 419 772 2985.
E-mail address: k-broekemeier@onu.edu (K.M. Broekemeier).Adam J. Rauckhorst a, Douglas R. Pfeiffer a,b,c, Kimberly M. Broekemeier d,⇑
aDepartment of Cellular and Molecular Biochemistry, The Ohio State University, Columbus, OH 43210, United States
b Internal Medicine, The Ohio State University, Columbus, OH 43210, United States
c Institute of Mitochondrial Biology, The Ohio State University, Columbus, OH 43210, United States
dDepartment of Chemistry and Biochemistry, Ohio Northern University, Ada, OH 45810, United States
a r t i c l e i n f o a b s t r a c tArticle history:
Received 14 April 2015
Revised 5 July 2015
Accepted 9 July 2015
Available online 20 July 2015






BioenergeticsPrevious reports from our lab identiﬁed a mitochondrial calcium-independent phospholipase A2
activity that is activated when the mitochondrial membrane potential is decreased. This activity
was demonstrated to inﬂuence occurrence of the permeability transition. Originally, this activity
was ascribed to the iPLA2b protein. Recently, both iPLA2b and iPLA2c knock out mice have been
generated. It has been shown by others that the iPLA2c plays a signiﬁcant role in progression of
the permeability transition. In this paper, using the iPLA2b and iPLA2c knock out mice we show that
the membrane potential sensitive activity is the iPLA2c.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
In a previous publication, we identiﬁed a calcium-independent
phospholipase A2 (iPLA2) activity in rat liver mitochondria that is
activated under conditions that produce loss of membrane poten-
tial (Dw), including addition of a protonophore, addition of alame-
thicin, or opening of the permeability transition pore [1]. This
activity was subsequently shown to play a facilitating role in
occurrence of the mitochondrial permeability transition and to
modulate release of cytochrome c from isolated mitochondria [2].
More recently, through use of select combinations of electron
transport inhibitors and substrates, we demonstrated that
increased activity is not determined by the redox status of any par-
ticular electron transport complex, that activation occurs in a
graded fashion, and that activation by de-energization is reversed
when an energized state is restored [3]. These regulatory featuressuggest that this activity is involved in sensing and coordinating
cellular bioenergetics and cellular fate.
Members of the phospholipase A2 superfamily are organized
into 16 groups (Group I–Group XVI) that are further divided into
many subgroups (For review see [4]). Group VI iPLA2s include the
calcium-independent phospholipase A2 that have activity in the
absence of calcium and have in common a catalytic serine at the
active site. Group VI is further divided into six subgroups based
on genetic code and physical structure. Group VIA and VIB iPLA2s
have been named the iPLA2b and iPLA2c, respectively. It has been
reported that each of these isozymes have a population that is
localized to the mitochondria [1,5–8].
The iPLA2b, encoded by the PNPLA9 gene, was ﬁrst puriﬁed and
characterized frommacrophage-like cells by Dennis and colleagues
[9]. Immunoblot analysis of Percoll puriﬁed mitochondria, using a
commercial antibody raised against the activity obtained by
Dennis, showed the presence of the iPLA2b and we initially attrib-
uted the calcium-independent phospholipase A2 activity to this
protein [1]. A similar activity was found independently in mito-
chondria from rabbit heart [5]. Additional Ca2+-independent
iPLA2 activities were identiﬁed in mitochondria from kidney
[7,10], brain [6], lung and spleen [8]. Based on immunoblot analy-
sis, using the commercially available antibody, the activities in
heart, and brain were also attributed to iPLA2b. An iPLA2b KO
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ogous recombination [11,12], and these mice have been employed
to identify roles for the iPLA2b in processes dependent upon arachi-
donic acid derived signaling molecules [13] and in generation of
platelet activating factor [13,14].
Gross and colleagues cloned the iPLA2c encoded by the PNPLA8
gene in 2000 [15]. Examination of the gene showed the presence of
both peroxisomal and mitochondrial targeting sequences [16]. This
dual localization was veriﬁed at the protein level in a myocardial
over expression model [17]. Additional evidence for a mitochon-
drial location of iPLA2c, came from the group of Schnellmann,
who showed inhibition of iPLA2 activity in isolated kidney mito-
chondria by the stereo speciﬁc inhibitor (R) bromoenol lactone
(R-BEL), which is relatively selective as an inhibitor of iPLA2c [7].
Gross and colleagues have generated an iPLA2c global knockout
mouse model by removing exon 5 from the PNPLA8 gene [18].
Using mitochondria isolated from the iPLA2c global knockout,
Moon et al. [19], showed a reduction in iPLA2 activity and that
progression of the permeability transition, as evidenced by the rate
of swelling, was reduced when compared to wild type counter
parts. Rapid swelling was recovered when palmitic acid was added
supporting a hypothesis that iPLA2c activity plays a role in opening
the permeability transition pore through release of FFA.
Our earlier work also identiﬁed a facilitating role for iPLA2 activ-
ity in the permeability transition [2]. The iPLA2 activity described
there has the speciﬁc regulatory feature of being membrane poten-
tial dependent [2] and it is of interest to determine whether that
potential sensitive activity can also be attributed to the iPLA2c.
The identity of the potential sensitive activity has not been
addressed by those examining isozymes present in mitochondria.
Assays employed by those groups do not utilize intact mitochon-
dria. Their assay systems commonly employ sonicated mitochon-
dria and exogenous radiolabeled phospholipid. That system is not
useful in determining the identity of the membrane potential sen-
sitive iPLA2, as sonication would disturb the membrane barrier,
resulting in mitochondria unable to maintain a membrane poten-
tial. This precludes observation of iPLA2 activity differences
between conditions that generate energized or de-energized mito-
chondria and thus cannot speciﬁcally address the identity of an
enzyme activity modulated by membrane potential.
With this in mind, we isolated liver mitochondria from both
iPLA2b and iPLA2c knockout animals and performed an in organello
product accumulation assay to determine iPLA2 activity after mito-
chondrial depolarization. We observed a signiﬁcant reduction in
release of polyunsaturated fatty acids (PUFA) in uncoupled mito-
chondria from iPLA2c knockout animals, although a residual activ-
ity remained. There was no decrease in membrane sensitive
release of fatty acids upon iPLA2b knockout. Thus, the present
study demonstrates that iPLA2c is the predominant membrane
potential sensitive activity, but leaves room for the interpretation
that additional mitochondrial phospholipases become active in
de-energized mitochondria. Additionally, it suggests that while
iPLA2b may be present in mitochondria, it is not the membrane
potential sensitive phospholipase and has distinct regulatory prop-
erties and physiological functions.
2. Materials and methods
2.1. Animals and reagents
Male iPLA2b null mice were a gift from Dr. John Turk, University
ofWashington, St. Louis,MO, USA;male iPLA2c null micewere a gift
from Dr. Richard W. Gross, University of Washington, St. Louis, MO,
USA. Male Sprague–Dawley rats (250 g) and male C57/B6 mice,
the background strain for the iPLA2b null and iPLA2c null mice, wereobtained from Harlan Laboratories, Indianapolis, IN, USA. Animals
were maintained by University Laboratory Animal Resources. All
procedures were approved by the Institutional Animal Care and
Use Committee of the Ohio State University.
Speciﬁc enantiomers of bromoenol lactone (R- and S-BEL) were
purchased from Cayman Chemical, Ann Arbor, MI, USA. The iPLA2b
speciﬁc antibody was a gift from Dr. Sasanka Ramanadham,
University of Alabama, Birmingham, AL, USA. iPLA2c speciﬁc anti-
body was purchased from Abcam, Cambridge, ENG. Anti-VDAC1
antibody was purchased from Cell Signaling Technology, Beverly,
MA, USA. Anti-mouse/anti-rabbit-HRP were purchased from
Cayman Chemicals, Ann Arbor, MI, USA. HRP chemiluminescent
substrate was purchased from Thermo Fisher Scientiﬁc, Waltham,
MA, USA. All other reagents were purchased from Sigma Aldrich,
St. Louis, MO, USA.
2.2. Mitochondrial isolation
Mouse or rat liver mitochondria were isolated by methods pre-
viously described [20]. Two mouse livers or one rat liver were
homogenized in ice cold media containing 230 mM mannitol,
70 mM sucrose, 3 mMHEPES, 0.2 mM EGTA and 2 mg/mL fatty acid
free BSA, pH 7.4. Centrifugation was performed as previously
described [20]. The ﬁnal mitochondrial pellet was suspended in
media containing 230 mM mannitol, 70 mM sucrose, and 3 mM
HEPES, pH 7.4 (MSH media) at a concentration of 50–60 mg/mL.
Protein concentration was determined by the Biuret method.
2.3. Determination of iPLA2 activity
Phospholipase activity was determined bymonitoring accumula-
tion of polyunsaturated free fatty acids (PUFA). Incubations were
conducted simultaneously in vessels open to the air with
constant stirring. Mitochondria were diluted to 1.0 mg/mL in MSH
solution containing 10mM succinate and 0.5 nmol/mg rotenone.
Cyclosporine A (0.5 nmol/mg) was present. Carbonyl cyanide
m-chlorophenyl hydrazone (CCCP) (1.0 nmol/mg) was added 2 min
after addition of mitochondria to dissipate the proton gradient.
When utilized, BEL (5 lM) was added 45 s after addition of
mitochondria.
Aliquots were taken at times indicated and a modiﬁed Folch
extraction performed [20]. 5.0 lg heptadecanoic acid was
employed as internal standard. The Folch emulsion was cen-
trifuged at 1000 rpm for 5 min. The lower organic phase was col-
lected and brought to dryness under nitrogen. Extracted lipids
were dissolved in 1.0 mL freshly distilled ether containing 100 lL
methanol. Diazomethane, 200 lL, was added to convert FFA to
fatty acid methyl esters (FAME). After 15 min at RT, samples were
brought to dryness under nitrogen. Samples were re-suspended in
1.0 mL hexane and stored overnight at 80 C under argon.
Prior to analysis, stored samples were brought to dryness under
nitrogen and suspended in 200 lL hexane. Samples were applied to
silica gel mini-columns and washed successively with 1.8 mL hex-
ane and 2.0 mL chloroform. FAME were eluted in 2.0 mL hex-
ane:ether (1:1). FAME were brought to dryness under nitrogen
and suspended in 12 lL hexane. They were separated and quanti-
ﬁed using a GLC equipped with a capillary column and a computing
integrator. Peak areas representing the amount of individual FFA
were converted to units of nmol/mg of mitochondrial protein by
comparison to the area of the heptadecanoic acid peak retention
times of individual FFA were determined by comparison to those
of known components in a commercially available standard mix-
ture (Nu-Chek Prep, Elysian, MN, USA). For the present study, the
sum of the released linoleic acid (18:2), arachidonic acid (20:4),
and docosahexenoic acid (22:6) were used as the indicator of
A.J. Rauckhorst et al. / FEBS Letters 589 (2015) 2367–2371 2369phospholipase A2 activity [21]. In wild type animals, the percent
distribution was 59%, 36%, and 5% respectively. In the iPLA2c KO
animals, there was variation in that percent distribution, as fol-
lows: 41%, 43%, 17%.
2.4. Immunoblot analysis
Isolated mitochondria were diluted and lysed in RIPA buffer
(50 mM Tris, pH 8.0, 150 mM NaCl, 1.0% Triton x-100, 0.5% deoxy-
cholate, 0.1% SDS, 5 mM EDTA, and 5 mM EGTA) supplemented
with a protease inhibitor cocktail (Roche, Nutley, NJ, USA). Equal
amounts of mitochondrial protein were loaded into the lanes of a
polyacrylamide gel. Gels were run at a constant 100 mV until sep-
aration was achieved, as determined by the separation of a
pre-stained protein standard (Bio-Rad Laboratories Inc., Hercules,
CA, USA). Proteins were transferred to a PVDF membrane by the
wet method at a constant 100 mV for 1.5 h. Membranes were incu-
bated in blocking solution (5% defatted dry milk in TBST) for 1 h at
room temperature before being washed three times in TBST to
remove excess blocking solution. Incubation with primary antibod-
ies took place overnight at 4 C. The primary antibody solution was
removed and membranes washed three times with TBST before
secondary HRP-linked antibody was added in blocking solution.
Membranes were visualized using ECL and exposed on X-ray ﬁlm.
3. Results and discussion
3.1. Effect of R- and S-BEL
The halide compound, BEL, selectively inhibits group VI iPLA2s
[22,23]. BEL contains one stereogenic center and exists as two
enantiomers. Puriﬁed enantiomers have been used to show that
S-BEL is 10-fold more reactive towards iPLA2b, whereas R-BEL is
selective for iPLA2c [24]. We employed S- and R-BEL to pharmaco-
logically identify the iPLA2 species in rat liver mitochondria that is
activated upon mitochondrial depolarization by the chemical
uncoupler, CCCP. When this protonophore was used to activate
iPLA2 there was no signiﬁcant difference in release of PUFA when
S-BEL was present compared to vehicle alone (Fig. 1). However,
when R-BEL was present there was an approximately 55%Fig. 1. Effect of R- and S-BEL on iPLA2 activity: rat liver mitochondria were
incubated at 1.0 mg/mL in the MSH medium containing succinate (10 mM),
rotenone (0.5 nmol/mg), and cyclosporine A (0.5 nmol/mg). The temperature was
25 C. BEL (5 lM) was added 45 s after the addition of mitochondria. CCCP
(1.0 nmol/mg) was added 2 min after the addition of mitochondria. Samples were
taken at the indicated time points and processed for free fatty acid determination as
described in the Section 2.d No addition of CCCP,s CCCP, but no addition of BEL,4
S-BEL added 45 s after addition of mitochondria, CCCP added, . R-BEL added 45 s
after addition of mitochondria, CCCP added. Values are the average of 3 indepen-
dent preparations ± S.E. (error bars).reduction in release of PUFA (Fig. 1). This data supports a hypoth-
esis that the iPLA2c and not the iPLA2b accounts for a signiﬁcant
portion of the membrane potential regulated release of FFA in iso-
lated mitochondria. It is important to note that, in the presence of
R-BEL, some PLA2 activity remains. Experiments by Schnellmann
and colleagues [7,10], utilizing BEL enantiomers to inhibit mito-
chondrial iPLA2s, show similar relative inhibitory activities.
3.2. iPLA2 activation in knockout animals
A membrane potential sensitive iPLA2 was also identiﬁed in
mice liver mitochondria that is sensitive to inhibition by racemic
BEL (Fig. 2). CCCP stimulated accumulation of PUFA was reduced
by 60% when racemic BEL was present in the incubation. This
was observable after 45 and 180 min of incubation. Since it is
known that the speciﬁcities of individual BEL enantiomers are
not absolute [24], we moved directly to examining iPLA2 activity
in the transgenic mice strains described above to determine the
isozyme responsible for the membrane potential sensitive activity.
Utilizing the iPLA2b and iPLA2c knockout mice, we monitored PUFA
accumulation in isolated liver mitochondria and demonstrate that
iPLA2c, is the enzyme responsible for the membrane potential sen-
sitive activity.
In Fig. 3A, it is shown that mitochondria isolated from wild type
mice, like those from rats, exhibited increased phospholipolysis
and accumulation of PUFA after uncoupling when compared to
those left untreated (Fig. 3A). The relative increase in iPLA2 activity
seen in the presence of uncoupler is similar to that seen in rat liver
mitochondria, although total free fatty acid accumulation was
greater in mouse liver mitochondria (Fig. 3A). Mitochondria from
the two knockout animals showed different magnitudes of PUFA
release in response to treatment by uncoupler. Mitochondria iso-
lated from iPLA2c knockout mice displayed a substantial decrease
in membrane potential sensitive iPLA2 activity when compared to
mitochondria from wild type mice similarly treated (Fig. 3A and B).
In contrast, mitochondria from iPLA2b knockout mice exhibited
uncoupler induced iPLA2 activity similar to that observed in wild
type animals (Fig. 3A and C). The reduction in accumulation of
PUFA after uncoupling in mitochondria from iPLA2c knock out
mice corresponds to 80% of that observed in mitochondria fromFig. 2. Mouse liver mitochondria contain a BEL sensitive iPLA2: incubations were
conducted as in Fig. 1, however mitochondria were isolated from mouse liver. The
ﬁrst group of three bars was obtained from an incubation in the absence of CCCP
and BEL. The second group of three bars was obtained from an incubation
containing CCCP (1.0 nmol/mg). The third set of three bars was obtained from an
incubation containing CCCP (1.0 nm/mg) and racemic BEL (5 lM). In each set, the
clear bar is the value obtained at t = 0, the lighter gray bar is the value determined at
45 min. and the darkest bar is the value determined at 180 min. The data is the
average from two separate preparations with individual values within 15% of each
other at each time point.
Fig. 3. iPLA2c is the enzyme responsible for most of the iPLA2 activity seen in depolarized liver mitochondria: Incubations were conducted as in Fig. 1, however mitochondria
were isolated from mouse liver. (A) Wild type mitochondria were incubated in the absence d or presence s of CCCP (1.0 nmol/mg). (B) iPLA2c-KO mitochondria were
incubated as in (A). (C) iPLA2b-KO mitochondria were incubated as in (A). (D) Western blot analysis of mitochondria isolated from wild type, iPLA2b-KO, and iPLA2c-KO mice
probed with antibodies against iPLA2b, iPLA2c, and the mitochondrial marker VDAC as loading control. Values in Panel (A) are the average of 5 independent preparations and
have a standard error of 10% or less. Values in Panels, (B), and (C) are the average of two independent preparations with values differing by 15% or less at all time points.
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In the absence of uncoupling, a low level of PUFA release was
observed for all animal genotypes (closed circles, Fig. 3A–C).
Western blot analyses were conducted in order to verify animal
genotype (Fig. 3D). No iPLA2b or iPLA2c protein was detected in
mitochondria isolated from iPLA2b and iPLA2c knockout mice,
respectively. Both proteins were found in wild type animals. This
data indicates that iPLA2c is the phospholipase species primarily
responsible for the depolarization dependent iPLA2 activity
observed in isolated rat and mouse liver mitochondria and is
consistent with results of the experiments carried out in rat liver
mitochondria utilizing BEL enantiomers (Fig. 1).
In previous publications, we discussed the relationships
between membrane potential, iPLA2 activity, and opening of the
permeability transition pore [1,2]. The data here, coupled with that
presented by Gross [19] strengthens those proposed relationships
and supports the hypothesis that changes in membrane potential
can affect occurrence of the permeability transition though release
of PUFA via a membrane potential sensitive phospholipase. This
could occur in numerous physiological and pathological conditions
including, reperfusion injury [25], identiﬁcation of poorly function-
ing mitochondria [26], and apoptosis [27]. Since the magnitude of
the mitochondrial membrane potential can be an indicator of the
functional status of mitochondria, modulations in iPLA2c activity
and released fatty acids are proposed to play a role in coordinating
cellular bioenergetics.
While identifying iPLA2c as the predominant membrane poten-
tial sensitive activity, these results question interpretations of ear-
lier data ascribing the membrane potential sensitive activity to the
iPLA2b [1,5,6]. This early hypothesis was developed based on
immunological studies of fractionated mitochondria showing the
presence of this protein in the membrane portion of Percoll puri-
ﬁed liver mitochondria. Although that data provides evidence of
a mitochondrial localization for the iPLA2b, the fact that mice
devoid of this isozyme retain iPLA2 activity after uncoupling
(Fig. 3C), argues against this protein being responsible for release
of FFA after depolarization. It has been shown by others, that the
iPLA2b interacts with numerous proteins, some of which increasephospholipase activity [28] while others decrease phospholipase
activity [29,30], we propose that iPLA2b activity is not
observed in our experimental system because this enzyme
is not regulated by membrane potential and that an additional
extra-mitochondrial factor required for activity is not present.
The iPLA2b likely functions in a distinct or secondary role within
the mitochondria rather than as a primary sensor of mitochondrial
bioenergetics as originally proposed [1]. Additional work is neces-
sary to reevaluate the role of the iPLA2b in mitochondria.
A ﬁnal aspect of the data presented here is that when iPLA2c is
ablated, a small level of membrane potential dependent activity
remains (Fig. 3B). We have also observed a low level of iPLA2 activ-
ity in the presence of racemic BEL in rat liver mitochondria when
activated by a number of different de-energizing compounds
[1,2] and in mouse liver when activated by addition of CCCP
(Fig. 2). These data imply the presence of an additional lipolytic
activity that may be partially regulated by membrane potential
and may rely on lM levels of calcium for activity. The presence
of other PLA2 activities is consistent with the data of Gross and col-
leagues [19]. In their recent paper, while immunoblot analysis con-
ﬁrmed the absence of iPLA2c in their knock out mice, signiﬁcant
release of arachidonic acid still observed (60% compared to wild
type) in mitochondria isolated from those mice. Additionally,
although progression of the permeability transition was signiﬁ-
cantly decreased in iPLA2c knock out mice, further inhibition of
the transition was observed when either R- or S-BEL was added,
indicating additional BEL sensitive activity.
Others have observed iPLA2 activities with unique regulatory
properties in mitochondria isolated from different tissues. In iso-
lated brain mitochondria an iPLA2 activity is present under basal
conditions that increases in activity upon slight depolarization as
induced by BAX and truncated BID. This activity is reduced below
basal activity in the presence of BEL [6,31]. Schnellmann and col-
leagues have identiﬁed an iPLA2 activity in rabbit renal cortex
mitochondria that is inhibited by CCCP rather than activated
[10]. The relationship of this activity to that identiﬁed in our stud-
ies is unclear due to the differing assay systems as mentioned
above. It is clear that further work is required to determine the
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ety of tissues.
3.3. Conclusion
Herein, we have demonstrated that the predominant protein
responsible for membrane potential sensitive iPLA2 activity is the
iPLA2c encoded by the PNPLA8 gene. Because activity of this
enzyme is closely linked to the bioenergetic status of mitochon-
dria, it is an excellent candidate for coordination of cellular pro-
cesses with the functional status of mitochondria.
Additionally, by utilizing iPLA2b knockout mice we have
demonstrated that the iPLA2b does not contribute to depolarization
induced iPLA2 even though its physical presence in mitochondria
has been documented [1,5,6].
Our results are consistent with the presence of additional phos-
pholipase activities that operate in conjunction with those already
identiﬁed or have distinct roles in mitochondrial function.
Activation of additional lipolytic activities may be linked to or
dependent upon activation of the membrane potential dependent
activity or may require additional factors.
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